Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity.
about
Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer.Both FA- and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution.PEGylation of bovine serum albumin using click chemistry for the application as drug carriers.Double-tailed acyl glycoside niosomal nanocarrier for enhanced oral bioavailability of Cefixime.Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability.A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.Methotrexate Nanoparticles Prepared with Codendrimer from Polyamidoamine (PAMAM) and Oligoethylene Glycols (OEG) Dendrons: Antitumor Efficacy in Vitro and in Vivo.Niosomes in sustained and targeted drug delivery: some recent advances.Bioresponsive nanosensors in medical imaging.Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin.Fluorescence-tagged gold nanoparticles for rapidly characterizing the size-dependent biodistribution in tumor models.Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study.Formulation and optimization of Zidovudine niosomes.Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin.Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety."Nano-Ginseng" for Enhanced Cytotoxicity AGAINST Cancer Cells.Nanovesicle delivery to the liver via retinol binding protein and platelet-derived growth factor receptors: how targeting ligands affect biodistribution.Creatinine-based non-phospholipid vesicular carrier for improved oral bioavailability of Azithromycin.Quantitative analysis of PEG-functionalized colloidal gold nanoparticles using charged aerosol detection.
P2860
Q30359589-00E2DAA7-8CBC-4A0A-AFB9-C4CC5768958EQ34057721-2FDD2738-B0ED-4EF6-BE7D-A23A87AAF9BCQ34139643-866D144E-24C0-4B4E-99D9-51BAF3B88052Q36185274-9E3E2DE5-EDB0-4880-842B-BBF18C944B66Q36379940-11C4518A-D22B-43F0-B879-386812E5EDA5Q37042592-47B4BF16-485B-4BFF-B867-497701C0D26EQ37076443-EE45D73E-6BD0-4335-991D-6AE51A09C6B3Q37618808-AD95E9E9-737E-48D1-9A26-BDDBA073164AQ37619125-5E0CBC8A-8D67-4AFB-A805-82DD452A2B2DQ38047267-F7047D75-EC7B-422F-B162-FDF49351B773Q38767228-E24F90F6-FA6E-4E82-B498-6935DC74E798Q39513720-5577F736-C861-4134-9AB1-55DB94EF85E7Q39915354-C21684D3-FF58-4154-B73E-18D6C03F1750Q41841747-1139BC49-C0CA-4166-95B1-834BFFAB4719Q44837755-327732FA-D686-413B-AD7E-45E584AC7F4CQ46528246-9C415011-4C53-4948-9773-B7576AAE6D6DQ50145811-7C0D5132-BB00-4991-BD46-9578F949942BQ51197424-C056DB90-15E3-4021-BFA4-424C4E92AAA0Q53528770-B92355EE-53AE-4471-BAA3-6FF469CE5367Q53591003-EA6EDA84-64CA-4B92-9530-12F5A891130C
P2860
Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Stealth PEG-PHDCA niosomes: ef ...... netics and antitumor activity.
@en
type
label
Stealth PEG-PHDCA niosomes: ef ...... netics and antitumor activity.
@en
prefLabel
Stealth PEG-PHDCA niosomes: ef ...... netics and antitumor activity.
@en
P2093
P356
P1476
Stealth PEG-PHDCA niosomes: ef ...... netics and antitumor activity.
@en
P2093
P304
P356
10.1002/JPS.20491
P407
P577
2006-09-01T00:00:00Z